Fibrocell Science Inc (FCSC)

[newtechinvestor]

Overhang caused by warrant conversion and offer to sell by preferred holders are putting lids on price appreciation from FDA approval, but it represent tremendous opportunity for those patient investors. I do believe this churning will be short lived.

I doubt 31 mil shares registered for sale will be sold on the market immediately. Possible some of the preferred shares maybe sold to pay for the uderlying warrant price ($0.50 per share) and hold the shares for longer term. I do think these shares available represent opportunity for fund and bigger pockets to do a private transactions. If that's the case, 13g or form 4 (insiders) should be forthcoming.